We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -20.00 | -0.16% | 12,106.00 | 12,120.00 | 12,122.00 | 12,190.00 | 12,024.00 | 12,080.00 | 999,558 | 16:35:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.55 | 187.98B |
Hot Features
Premium
RNS Number:5483K
AstraZeneca PLC
30 April 2003
AstraZeneca PLC: Hakan Mogren to become Non-Executive Director
AstraZeneca PLC announced today that Dr Hakan Mogren, currently Executive Deputy
Chairman, will cease to be an Executive Director of the Company on 31 August
2003. With effect from that date, he will become Non-Executive Deputy Chairman.
Dr Mogren, 58, was the Chief Executive Officer of Astra AB between 1988 and
1999. On the merger with Zeneca Group PLC in April 1999, Dr Mogren became
Executive Deputy Chairman of the merged group.
Graeme Musker
Company Secretary
30 April 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOASDWSUSSDSEDL
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
